Search research articles
Contact Us
Filters
Showing results (471-480 of 599) with videos related to
Page
of 60
Sort By:
The Journal of Infectious Diseases
|
October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients
S G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology
|
December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients
A K Burn, A W Fothergill, W R Kirkpatrick, et al.
Journal of the American Veterinary Medical Association
|
September 1, 1989
Testicular feminization in a cat
V N Meyers-Wallen, J D Wilson, J E Griffin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group
Raoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer
Spencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Journal of Clinical Microbiology
|
December 23, 2011
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection
Martina Lengerova, Iva Kocmanova, Zdenek Racil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients
S G Revankar, O P Dib, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea, J L López-Ribot, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy
|
December 28, 2007
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis
Nathan P Wiederhold, Laura K Najvar, Ana C Vallor, et al.
Medicine
|
August 15, 2000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group
T F Patterson, W R Kirkpatrick, M White, et al.
Page
of 60
Search research articles
Search
Showing results (471-480 of 599) with videos related to
Sort By:
Page
of 60
The Journal of Infectious Diseases
|
October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients
S G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology
|
December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients
A K Burn, A W Fothergill, W R Kirkpatrick, et al.
Journal of the American Veterinary Medical Association
|
September 1, 1989
Testicular feminization in a cat
V N Meyers-Wallen, J D Wilson, J E Griffin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group
Raoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer
Spencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Journal of Clinical Microbiology
|
December 23, 2011
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection
Martina Lengerova, Iva Kocmanova, Zdenek Racil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients
S G Revankar, O P Dib, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
S Perea, J L López-Ribot, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy
|
December 28, 2007
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis
Nathan P Wiederhold, Laura K Najvar, Ana C Vallor, et al.
Medicine
|
August 15, 2000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group
T F Patterson, W R Kirkpatrick, M White, et al.
Page
of 60